USA - NASDAQ:DOX - GB0022569080 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to DOX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-07-08 | Wolfe Research | Initiate | Outperform | 
| 2024-11-14 | Barclays | Maintains | Overweight -> Overweight | 
| 2024-11-13 | Oppenheimer | Maintains | Outperform -> Outperform | 
| 2024-10-02 | Stifel | Initiate | Buy | 
| 2024-05-09 | Baird | Maintains | Neutral -> Neutral | 
| 2024-05-09 | Citigroup | Maintains | Buy -> Buy | 
| 2024-02-08 | Barclays | Maintains | Overweight -> Overweight | 
| 2024-01-17 | Citigroup | Maintains | Buy -> Buy | 
| 2023-12-01 | Jefferies | Initiate | Buy | 
| 2023-08-03 | Oppenheimer | Maintains | Outperform -> Outperform | 
| 2023-05-16 | Barclays | Upgrade | Equal-Weight -> Overweight | 
| 2023-05-11 | Oppenheimer | Reiterate | Outperform -> Outperform | 
| 2023-02-02 | Baird | Maintains | Neutral | 
| 2023-02-01 | Oppenheimer | Maintains | Outperform | 
| 2022-11-09 | Citigroup | Maintains | Buy | 
| 2022-08-04 | Barclays | Maintains | Equal-Weight | 
| 2022-08-04 | Citigroup | Maintains | Buy | 
| 2022-05-12 | Citigroup | Maintains | Buy | 
| 2021-12-14 | JP Morgan | Downgrade | Overweight -> Neutral | 
| 2021-08-05 | Oppenheimer | Maintains | Outperform | 
12 analysts have analysed DOX and the average price target is 105.97 USD. This implies a price increase of 26.12% is expected in the next year compared to the current price of 84.02.
The consensus rating for AMDOCS LTD (DOX) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering AMDOCS LTD (DOX) is 12.